Acid suppression therapy: where do we go from here? (Q36478082)

14 August 2017

1 reference

title

Acid suppression therapy: where do we go from here? (English)

1 reference

14 August 2017

Carmelo Scarpignato

1

1 reference

PubMed ID

16699262

14 August 2017

Iva Pelosini

series ordinal

2

1 reference

PubMed ID

16699262

14 August 2017

Francesco Di Mario

series ordinal

3

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

24

1 reference

14 August 2017

1-2

1 reference

14 August 2017

11-46

1 reference

A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole

14 August 2017

1 reference

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

21 January 2018

1 reference

Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.

21 January 2018

1 reference

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

21 January 2018

1 reference

Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis

21 January 2018

1 reference

Treatment of Helicobacter pylori infection. Indications and regimens: an update

21 January 2018

1 reference

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

21 January 2018

1 reference

Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers

21 January 2018

1 reference

Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.

21 January 2018

1 reference

Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer

21 January 2018

1 reference

Pharmacogenetics of the proton pump inhibitors: a systematic review.

21 January 2018

1 reference

Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors

21 January 2018

1 reference

Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study

21 January 2018

1 reference

Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors

21 January 2018

1 reference

Protective Effect of Lafutidine, a Novel H2-Receptor Antagonist, on Reflux Esophagitis in Rats Through Capsaicin-Sensitive Afferent Neurons

21 January 2018

1 reference

Protective effect of lafutidine, a novel histamine H2-receptor antagonist, on dextran sulfate sodium-induced colonic inflammation through capsaicin-sensitive afferent neurons in rats

21 January 2018

1 reference

Gastrin as a growth factor in the gastrointestinal tract

21 January 2018

1 reference

(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist

21 January 2018

1 reference

Edkins and a century of acid suppression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000091298

1 reference

14 August 2017

1 reference

PubMed ID

16699262